Corcept Therapeutics Ownership 2024 | Who Owns Corcept Therapeutics Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

90.07%

Insider Ownership

11.39%

Retail Ownership

-1.46%

Institutional Holders

301.00

Corcept Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.16.42%0.01%16,826,081418,3852.55%423,848,981Mar 31, 2024
VANGUARD GROUP INC9.34%0.00%9,565,78228,2500.30%240,962,048Mar 31, 2024
INGALLS & SNYDER LLC8.10%9.23%8,303,147-48,680-0.58%209,156,000Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC6.95%0.28%7,118,371392,5005.84%179,312,000Mar 31, 2024
PARALLEL ADVISORS, LLC3.72%2.60%3,815,67747,4321.26%96,116,904,000Mar 31, 2024
STATE STREET CORP3.49%0.00%3,575,526188,0615.55%90,067,500Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP2.51%0.02%2,567,677257,38011.14%64,679,784Mar 31, 2024
NOVO HOLDINGS A/S2.35%4.19%2,411,362--60,742,209Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC2.11%0.01%2,157,785112,1395.48%54,362,204Mar 31, 2024
FIRST TRUST ADVISORS LP1.79%0.05%1,838,8121,691,8041150.82%46,319,674Mar 31, 2024
BOSTON TRUST WALDEN CORP1.79%0.33%1,835,093-11,831-0.64%46,225,992Mar 31, 2024
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1.65%0.04%1,686,671585,56853.18%42,487,000Mar 31, 2024
MORGAN STANLEY1.48%0.00%1,513,078216,94216.74%38,114,434Mar 31, 2024
MAN GROUP PLC1.46%0.10%1,498,920672,81981.45%37,757,795Mar 31, 2024
D. E. SHAW & CO., INC.1.11%0.02%1,133,084-525,554-31.69%28,542,386Mar 31, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC1.01%0.10%1,033,225485,92888.79%26,026,938Mar 31, 2024
IKARIAN CAPITAL, LLC0.97%2.73%994,500723,200266.57%25,051,455Mar 31, 2024
NORTHERN TRUST CORP0.94%0.00%963,443-128,055-11.73%24,269,129Mar 31, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC0.91%0.01%933,46133,0173.67%23,513,882Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.85%0.00%873,200873,200100.00%21,995,908Mar 31, 2024

Corcept Therapeutics's largest institutional shareholder is BLACKROCK INC., holding 16.42% of the company's total share outstanding, currently valued at $423.85M. The top 10 institutional shareholders own together 56.79% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
INGALLS & SNYDER LLC8.10%9.23%8,303,147-48,680-0.58%209,156,000Mar 31, 2024
TANAKA CAPITAL MANAGEMENT INC0.09%5.63%90,87653,785145.01%2,289,000Mar 31, 2024
CHECKPOINT CAPITAL L.P.0.27%4.61%273,776273,776100.00%6,896,417Mar 31, 2024
NOVO HOLDINGS A/S2.35%4.19%2,411,362--60,742,209Mar 31, 2024
IKARIAN CAPITAL, LLC0.97%2.73%994,500723,200266.57%25,051,455Mar 31, 2024
PARALLEL ADVISORS, LLC3.72%2.60%3,815,67747,4321.26%96,116,904,000Mar 31, 2024
QUANTEDGE CAPITAL PTE LTD0.18%1.91%180,642-67,700-27.26%4,550,372Mar 31, 2024
KYNAM CAPITAL MANAGEMENT, LP0.57%1.54%585,900--14,758,821Mar 31, 2024
S&T BANK/PA0.28%1.40%290,487-30,349-9.46%7,317,000Mar 31, 2024
ALPHACENTRIC ADVISORS LLC0.08%1.29%85,00085,000100.00%2,141,150Mar 31, 2024
BIRCHVIEW CAPITAL, LP0.05%1.03%50,000--1,259,500Mar 31, 2024
CAPITAL IMPACT ADVISORS, LLC0.03%0.87%26,53726,537100.00%668,467Mar 31, 2024
IKARIAN CAPITAL, LLC0.27%0.77%279,5008,2003.02%7,040,605Mar 31, 2024
FAS WEALTH PARTNERS, INC.0.30%0.70%311,3831,0920.35%7,843,738Mar 31, 2024
HUSSMAN STRATEGIC ADVISORS, INC.0.08%0.49%84,00031,50060.00%2,115,960Mar 31, 2024
BRIDGE CITY CAPITAL, LLC0.05%0.46%49,6383860.78%1,250,381Mar 31, 2024
CLEARVIEW WEALTH ADVISORS LLC0.01%0.37%14,38214,382100.00%362,283Mar 31, 2024
BOSTON TRUST WALDEN CORP1.79%0.33%1,835,093-11,831-0.64%46,225,992Mar 31, 2024
EXECUTIVE WEALTH MANAGEMENT, LLC0.14%0.32%140,690115,690462.76%3,621,361Mar 31, 2024
ENTRYPOINT CAPITAL, LLC0.01%0.31%13,7864,80253.45%347,269Mar 31, 2024

The largest Corcept Therapeutics shareholder by % of total assets is INGALLS & SNYDER LLC. The company owns 8.30M shares of Corcept Therapeutics (CORT), representing 9.23% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FIRST TRUST ADVISORS LP1.79%0.05%1,838,8121,691,8041150.82%46,319,674Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.85%0.00%873,200873,200100.00%21,995,908Mar 31, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC0.71%0.08%731,468731,468100.00%18,425,679Mar 31, 2024
IKARIAN CAPITAL, LLC0.97%2.73%994,500723,200266.57%25,051,455Mar 31, 2024
JUPITER ASSET MANAGEMENT LTD0.73%0.18%744,469684,8631148.98%18,753,174Mar 31, 2024
MAN GROUP PLC1.46%0.10%1,498,920672,81981.45%37,757,795Mar 31, 2024
CERITY PARTNERS LLC0.66%0.04%675,843601,776812.48%17,024,484Mar 31, 2024
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1.65%0.04%1,686,671585,56853.18%42,487,000Mar 31, 2024
CLEARBRIDGE INVESTMENTS, LLC0.57%0.01%582,355582,355100.00%14,669,533Mar 31, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC1.01%0.10%1,033,225485,92888.79%26,026,938Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.49%0.01%498,700480,9002701.69%12,562,253Mar 31, 2024
BLACKROCK INC.16.42%0.01%16,826,081418,3852.55%423,848,981Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.40%0.00%410,500410,500100.00%10,340,495Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC6.95%0.28%7,118,371392,5005.84%179,312,000Mar 31, 2024
BANK OF AMERICA CORP /DE/0.66%0.00%673,354385,951134.29%16,961,787,000Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.80%0.05%818,475340,91871.39%20,617,385Mar 31, 2024
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.0.32%0.03%324,271313,5432922.66%8,168,000Mar 31, 2024
CHECKPOINT CAPITAL L.P.0.27%4.61%273,776273,776100.00%6,896,417Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP2.51%0.02%2,567,677257,38011.14%64,679,784Mar 31, 2024
TWO SIGMA ADVISERS, LP0.74%0.04%760,200223,80041.72%19,149,438Mar 31, 2024

As of Mar 31 2024, Corcept Therapeutics's largest institutional buyer is FIRST TRUST ADVISORS LP. The company purchased 1.69M stocks of CORT, valued at $46.32M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FEDERATED HERMES, INC.0.05%0.00%49,906-1,639,823-97.05%1,257,132Mar 31, 2024
D. E. SHAW & CO., INC.1.11%0.02%1,133,084-525,554-31.69%28,542,386Mar 31, 2024
INTRINSIC EDGE CAPITAL MANAGEMENT LLC----466,876-100.00%-Mar 31, 2024
GREAT LAKES ADVISORS, LLC----335,895-100.00%-Mar 31, 2024
GRANITE INVESTMENT PARTNERS, LLC----309,698-100.00%-Mar 31, 2024
SG AMERICAS SECURITIES, LLC0.01%0.00%6,831-206,979-96.81%172,000Mar 31, 2024
CITADEL ADVISORS LLC0.26%0.00%264,309-177,650-40.20%6,657,944Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.54%0.01%553,007-137,069-19.86%13,930,246Mar 31, 2024
NORTHERN TRUST CORP0.94%0.00%963,443-128,055-11.73%24,269,129Mar 31, 2024
ALGERT GLOBAL LLC----122,120-100.00%-Mar 31, 2024
GOLDMAN SACHS GROUP INC0.42%0.00%434,722-98,038-18.40%10,950,647Mar 31, 2024
LMR PARTNERS LLP----96,900-100.00%-Mar 31, 2024
JANE STREET GROUP, LLC0.02%0.00%17,934-73,244-80.33%451,758Mar 31, 2024
QUANTEDGE CAPITAL PTE LTD0.18%1.91%180,642-67,700-27.26%4,550,372Mar 31, 2024
BANK OF NEW YORK MELLON CORP0.71%0.00%724,022-48,732-6.31%18,238,115Mar 31, 2024
INGALLS & SNYDER LLC8.10%9.23%8,303,147-48,680-0.58%209,156,000Mar 31, 2024
ALLIANCEBERNSTEIN L.P.0.19%0.00%199,354-45,141-18.46%5,021,727Mar 31, 2024
KENNEDY CAPITAL MANAGEMENT LLC----44,929-100.00%-Mar 31, 2024
NUVEEN ASSET MANAGEMENT, LLC0.21%0.00%219,037-44,354-16.84%5,517,541Mar 31, 2024
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL)----43,600-100.00%-Mar 31, 2024

As of Mar 31 2024, Corcept Therapeutics's biggest institutional seller is FEDERATED HERMES, INC.. The company sold -1.64M shares of CORT, valued at $1.26M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.85%0.00%873,200873,200100.00%21,995,908Mar 31, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC0.71%0.08%731,468731,468100.00%18,425,679Mar 31, 2024
CLEARBRIDGE INVESTMENTS, LLC0.57%0.01%582,355582,355100.00%14,669,533Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.40%0.00%410,500410,500100.00%10,340,495Mar 31, 2024
CHECKPOINT CAPITAL L.P.0.27%4.61%273,776273,776100.00%6,896,417Mar 31, 2024
COMMONWEALTH EQUITY SERVICES, LLC0.19%0.01%191,577191,577100.00%4,826,000Mar 31, 2024
BARCLAYS PLC0.18%0.00%180,000180,000100.00%4,534,000Mar 31, 2024
TOWNSQUARE CAPITAL LLC0.11%0.04%117,133117,133100.00%2,950,580Mar 31, 2024
NORDEN GROUP LLC0.11%0.23%116,850116,850100.00%2,943,452Mar 31, 2024
JEFFERIES FINANCIAL GROUP INC.0.10%0.02%103,553103,553100.00%2,608,500Mar 31, 2024
ALPHACENTRIC ADVISORS LLC0.08%1.29%85,00085,000100.00%2,141,150Mar 31, 2024
CRESSET ASSET MANAGEMENT, LLC0.07%0.01%70,09070,090100.00%1,765,567Mar 31, 2024
LPL FINANCIAL LLC0.07%0.00%67,04667,046100.00%1,688,889Mar 31, 2024
EDGESTREAM PARTNERS, L.P.0.06%0.08%60,29160,291100.00%1,518,730Mar 31, 2024
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.0.05%0.00%50,10550,105100.00%1,262,145Mar 31, 2024
HAP TRADING, LLC0.05%0.00%50,00050,000100.00%32,500Mar 31, 2024
HAP TRADING, LLC0.05%0.02%50,00050,000100.00%143,750Mar 31, 2024
HUDSON BAY CAPITAL MANAGEMENT LP0.05%0.01%47,56947,569100.00%1,198,263Mar 31, 2024
MILESTONE ASSET MANAGEMENT, LLC0.03%0.25%35,00635,006100.00%881,802Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.03%0.00%33,81733,817100.00%851,850Mar 31, 2024
J. GOLDMAN & CO LP0.03%0.03%33,80033,800100.00%851,422Mar 31, 2024
KESTRA ADVISORY SERVICES, LLC0.03%0.01%30,83430,834100.00%776,708Mar 31, 2024
JANNEY MONTGOMERY SCOTT LLC0.03%0.00%28,01028,010100.00%706,000Mar 31, 2024
RAYMOND JAMES & ASSOCIATES0.03%0.00%27,54927,549100.00%693,959Mar 31, 2024
CAPTION MANAGEMENT, LLC0.03%0.01%27,00027,000100.00%680,130Mar 31, 2024
CAPITAL IMPACT ADVISORS, LLC0.03%0.87%26,53726,537100.00%668,467Mar 31, 2024
WALLEYE TRADING LLC0.02%0.00%24,20024,200100.00%609,598Mar 31, 2024
AXA S.A.0.02%0.00%22,62222,622100.00%569,848Mar 31, 2024
DRW SECURITIES, LLC0.02%0.01%21,10021,100100.00%531,509Mar 31, 2024
J. GOLDMAN & CO LP0.02%0.02%20,25020,250100.00%510,098Mar 31, 2024
UNISUPER MANAGEMENT PTY LTD0.02%0.00%17,53617,536100.00%441,732Mar 31, 2024
CETERA ADVISOR NETWORKS LLC0.02%0.00%17,44517,445100.00%439,440Mar 31, 2024
ARKADIOS WEALTH ADVISORS0.02%0.03%17,22717,227100.00%433,948Mar 31, 2024
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC0.01%0.02%14,74014,740100.00%371,301Mar 31, 2024
NEW YORK LIFE INVESTMENT MANAGEMENT LLC0.01%0.00%14,40714,407100.00%362,912Mar 31, 2024
ANCORA ADVISORS, LLC0.01%0.01%14,38814,388100.00%362,434,000Mar 31, 2024
ATRIA WEALTH SOLUTIONS, INC.0.01%0.00%13,85813,858100.00%349,083Mar 31, 2024
CETERA ADVISORS LLC0.01%0.00%13,50213,502100.00%340,115Mar 31, 2024
SAVANT CAPITAL, LLC0.01%0.00%12,72312,723100.00%320,493Mar 31, 2024
M&T BANK CORP0.01%0.00%11,57011,570100.00%291,076Mar 31, 2024
0.01%0.01%10,63910,639100.00%267,985Mar 31, 2024
CWA ASSET MANAGEMENT GROUP, LLC0.01%0.01%9,7439,743100.00%245,426Mar 31, 2024
ALPHAMARK ADVISORS, LLC0.01%0.08%9,3759,375100.00%236,000Mar 31, 2024
ROMAN BUTLER FULLERTON & CO0.01%0.08%9,2749,274100.00%206,810Mar 31, 2024
SOUND INCOME STRATEGIES, LLC0.00%0.01%4,9594,959100.00%124,917,000Mar 31, 2024
WALLEYE TRADING LLC0.00%0.00%4,8004,800100.00%120,912Mar 31, 2024
WELLS FARGO & COMPANY/MN0.00%-2,6002,600100.00%65,494,000Mar 31, 2024
NVERSES CAPITAL, LLC0.00%0.14%2,4002,400100.00%60,456,000Mar 31, 2024
INGALLS & SNYDER LLC0.00%0.00%1,5001,500100.00%38,000Mar 31, 2024
CIBC PRIVATE WEALTH GROUP, LLC0.00%0.00%1,0751,075100.00%27,671,000Mar 31, 2024
HEXAGON CAPITAL PARTNERS LLC0.00%0.00%376376100.00%9,471Mar 31, 2024
PRIVATE TRUST CO NA0.00%0.00%246246100.00%6,197Mar 31, 2024
HARBOR INVESTMENT ADVISORY, LLC0.00%0.00%8282100.00%2,066,000Mar 31, 2024
UMB BANK, N.A.--3939100.00%982Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC--1616100.00%403Mar 31, 2024

Corcept Therapeutics's largest new institutional shareholder by number of shares is SUSQUEHANNA INTERNATIONAL GROUP, LLP, purchased 873.20K shares, valued at $22.00M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
INTRINSIC EDGE CAPITAL MANAGEMENT LLC----466,876-100.00%-Mar 31, 2024
GREAT LAKES ADVISORS, LLC----335,895-100.00%-Mar 31, 2024
GRANITE INVESTMENT PARTNERS, LLC----309,698-100.00%-Mar 31, 2024
ALGERT GLOBAL LLC----122,120-100.00%-Mar 31, 2024
LMR PARTNERS LLP----96,900-100.00%-Mar 31, 2024
KENNEDY CAPITAL MANAGEMENT LLC----44,929-100.00%-Mar 31, 2024
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL)----43,600-100.00%-Mar 31, 2024
EMPOWERED FUNDS, LLC----41,067-100.00%-Mar 31, 2024
OCCUDO QUANTITATIVE STRATEGIES LP----36,510-100.00%-Mar 31, 2024
CAMPBELL & CO INVESTMENT ADVISER LLC----32,578-100.00%-Mar 31, 2024
PEARL RIVER CAPITAL, LLC----24,954-100.00%-Mar 31, 2024
INSPIRE INVESTING, LLC----24,462-100.00%-Mar 31, 2024
CENTIVA CAPITAL, LP----13,498-100.00%-Mar 31, 2024
BI ASSET MANAGEMENT FONDSMAEGLERSELSKAB A/S----12,851-100.00%-Mar 31, 2024
CIPHER CAPITAL LP----11,719-100.00%-Mar 31, 2024
APG ASSET MANAGEMENT N.V.----11,000-100.00%-Mar 31, 2024
CONVERGENCE INVESTMENT PARTNERS, LLC----10,982-100.00%-Mar 31, 2024
ATLAS CAPITAL ADVISORS LLC----10,905-100.00%-Mar 31, 2024
GRAHAM CAPITAL MANAGEMENT, L.P.----8,094-100.00%-Mar 31, 2024
DIVERSIFIED TRUST CO----7,656-100.00%-Mar 31, 2024
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC----7,013-100.00%-Mar 31, 2024
BALYASNY ASSET MANAGEMENT L.P.----6,993-100.00%-Mar 31, 2024
EVERGREEN CAPITAL MANAGEMENT LLC----6,651-100.00%-Mar 31, 2024
SYON CAPITAL LLC----6,307-100.00%-Mar 31, 2024
CORNERSTONE INVESTMENT PARTNERS, LLC----6,233-100.00%-Mar 31, 2024
AMUNDI----5,981-100.00%-Mar 31, 2024
POINT72 HONG KONG LTD----2,027-100.00%-Mar 31, 2024
PLANNED SOLUTIONS, INC.----1,400-100.00%-Mar 31, 2024
NEWEDGE ADVISORS, LLC----1,178-100.00%-Mar 31, 2024
GLADIUS CAPITAL MANAGEMENT LP----1,098-100.00%-Mar 31, 2024
FNY INVESTMENT ADVISERS, LLC----1,000-100.00%-Mar 31, 2024
JOHNSON FINANCIAL GROUP, INC.----608-100.00%-Mar 31, 2024
BENJAMIN F. EDWARDS & COMPANY, INC.----234-100.00%-Mar 31, 2024
ARLINGTON TRUST CO LLC----43-100.00%-Mar 31, 2024
CAROLINAS WEALTH CONSULTING LLC----27-100.00%-Mar 31, 2024
ADVISORNET FINANCIAL, INC----23-100.00%-Mar 31, 2024
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO----20-100.00%-Mar 31, 2024
C M BIDWELL & ASSOCIATES LTD----10-100.00%-Mar 31, 2024
ROSENBERG MATTHEW HAMILTON----2-100.00%-Mar 31, 2024

Corcept Therapeutics's largest sold out institutional shareholder by shares sold is INTRINSIC EDGE CAPITAL MANAGEMENT LLC, sold -0.47M shares, valued at -, as of undefined.

Corcept Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
TANAKA FUNDS INC1.84%41,25524,600147.70%Feb 29, 2024
COPLEY FUND INC /NV/1.11%15,000--Nov 30, 2022
BlackRock Advantage SMID Cap Fund, Inc.0.39%73,62262,119540.02%Dec 29, 2023
DSS AMERICAFIRST QUANTITATIVE FUNDS0.30%6,870--Dec 29, 2023
Nuveen NASDAQ 100 Dynamic Overwrite Fund0.29%36,349--Dec 31, 2023
BOSTON TRUST WALDEN FUNDS0.28%779,150-2,425-0.31%Dec 29, 2023
EntrepreneurShares Series Trust0.27%72,794--Dec 31, 2023
World Funds Trust0.24%136,94011,0518.78%Jan 31, 2024
ROYCE VALUE TRUST, INC.0.23%267,800-17,029-5.98%Dec 31, 2023
AMG FUNDS III0.19%31,700--Feb 29, 2024
VIRTUS ALTERNATIVE SOLUTIONS TRUST0.15%579--Jan 31, 2024
VANGUARD ADMIRAL FUNDS0.12%526,34254,34111.51%Feb 29, 2024
VANGUARD VALLEY FORGE FUNDS0.12%57,704--Dec 31, 2023
BNY MELLON INDEX FUNDS, INC.0.08%91,248-12,674-12.20%Jan 31, 2024
BNY MELLON INVESTMENT PORTFOLIOS0.08%44,708-232-0.52%Mar 31, 2024
Starboard Investment Trust0.07%26,600--Feb 29, 2024
AMERICAN CENTURY GROWTH FUNDS, INC.0.06%9,678--Jan 31, 2024
Voya VARIABLE PRODUCTS TRUST0.05%14,251--Dec 31, 2023
SYNTAX ETF TRUST0.04%1,412-168-10.63%Dec 31, 2023
Humankind Benefit Corp0.04%87814619.95%Dec 31, 2023
STATE STREET INSTITUTIONAL FUNDS0.03%28,448--Dec 31, 2023
Voya EQUITY TRUST0.03%45,019--Feb 29, 2024
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND0.03%114,08813,93713.92%Jan 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.03%12,3192872.39%Dec 31, 2023
360 Funds0.03%1,13929034.16%Feb 29, 2024
QUANTITATIVE MASTER SERIES LLC0.02%146,13410,0417.38%Dec 31, 2023
Federated Hermes MDT Series0.02%47,7011,0462.24%Jan 31, 2024
VANGUARD INDEX FUNDS0.02%8,506,1191,407,42419.83%Dec 31, 2023
VANGUARD QUANTITATIVE FUNDS0.02%150,80095,900174.68%Dec 31, 2023
HUSSMAN INVESTMENT TRUST0.01%52,500-10,500-16.67%Dec 31, 2023
AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC.0.01%33,308--Dec 31, 2023
JNL VARIABLE FUND LLC0.01%76,693--Mar 31, 2020
Bernstein Fund Inc0.01%142,37477,110118.15%Dec 31, 2023
BNY Mellon Strategic Funds, Inc.0.01%29,522--Mar 31, 2024
STEWARD FUNDS, INC.0.01%28,980--Jan 31, 2024
FIDELITY SELECT PORTFOLIOS0.01%765,599135,76321.56%Feb 29, 2024
Nushares ETF Trust0.01%85,767--Jan 31, 2024
Vericimetry Funds0.01%1,210--Dec 31, 2023
IndexIQ ETF Trust0.01%25,447--Jan 31, 2024
TIAA SEPARATE ACCOUNT VA 10.01%2,558--Dec 31, 2023
ROYCE FUND0.01%64,00010,00018.52%Dec 31, 2023
PFM Multi-Manager Series Trust0.01%8,324--Dec 31, 2023
FIDELITY COMMONWEALTH TRUST0.01%31,0314961.62%Feb 29, 2024
US GLOBAL INVESTORS FUNDS0.01%55,260--Dec 31, 2023
FEDERATED HERMES INSURANCE SERIES0.01%40,800--Dec 31, 2023
JAMES ADVANTAGE FUNDS0.01%18,033--Dec 31, 2023
EXCHANGE TRADED CONCEPTS TRUST0.01%45,2782,0864.83%Feb 29, 2024
BRIDGEWAY FUNDS INC0.01%19,000--Dec 29, 2023
WESMARK FUNDS0.01%23,152--Mar 31, 2024
FIRST TRUST EXCHANGE-TRADED FUND VI0.01%29,549--Dec 31, 2023
ALPS ETF Trust0.01%78,0725,6337.78%Feb 29, 2024
VANGUARD EXPLORER FUND0.01%75,12830,28767.54%Jan 31, 2024
TrimTabs ETF Trust0.01%3,6232838.47%Jan 31, 2024
Lattice Strategies Trust0.01%10,283-126-1.21%Dec 31, 2023
RBB Fund Trust0.01%5,083--Feb 29, 2024
ETF Series Solutions0.01%88,5308,28010.32%Feb 29, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%404,280-131,504-24.54%Jan 31, 2024
Principal Exchange-Traded Funds0.00%52,63621,16167.23%Mar 31, 2024
Mutual of America Variable Insurance Portfolios, Inc.0.00%3,083-116-3.63%Sep 30, 2023
FIDELITY CONCORD STREET TRUST0.00%855,51817,7602.12%Feb 29, 2024
ADVISORS' INNER CIRCLE FUND0.00%48,200--Jan 31, 2024
MUTUAL OF AMERICA INVESTMENT CORP0.00%144,97239,33837.24%Dec 31, 2023
Calvert Variable Products, Inc.0.00%8,3083344.19%Dec 31, 2023
SCHWAB STRATEGIC TRUST0.00%627,85738,3046.50%Feb 29, 2024
UNIFIED SERIES TRUST0.00%12,000--Feb 29, 2024
HARBOR FUNDS0.00%62,300--Jan 31, 2024
SHELTON FUNDS0.00%4,407--Feb 29, 2024
SSGA FUNDS0.00%1,096--Feb 29, 2024
VANGUARD HORIZON FUNDS0.00%46,230--Dec 31, 2023
VANGUARD TAX-MANAGED FUNDS0.00%705,0115,8320.83%Dec 31, 2023
DFA INVESTMENT DIMENSIONS GROUP INC0.00%2,077,142523,64933.71%Jan 31, 2024
OHIO NATIONAL FUND INC0.00%38,541--Dec 31, 2023
FIDELITY COVINGTON TRUST0.00%25,8425,13224.78%Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%53,616--Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND II0.00%20,158-1,203-5.63%Dec 31, 2023
SunAmerica Specialty Series0.00%792--Apr 30, 2021
Fidelity Commonwealth Trust II0.00%9,583-19,479-67.03%Aug 31, 2023
Advisors' Inner Circle Fund III0.00%20,322--Jan 31, 2024
VANGUARD WORLD FUND0.00%311,0403,5711.16%Feb 29, 2024
PRUDENTIAL SERIES FUND0.00%95,392-1,800-1.85%Dec 29, 2023
AMERICAN CENTURY ETF TRUST0.00%128,64489,694230.28%Feb 29, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%60,972-3,062-4.78%Dec 31, 2023
T. Rowe Price Index Trust, Inc.0.00%19,482--Feb 29, 2024
GPS Funds I0.00%5,510--Dec 31, 2023
TIMOTHY PLAN0.00%4,704--Mar 31, 2024
STONE RIDGE TRUST0.00%23,604--Jan 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%32,219-112-0.35%Dec 31, 2023
Dimensional ETF Trust0.00%444,09160,34315.72%Jan 31, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%3,447--Dec 31, 2023
NEW COVENANT FUNDS0.00%3,878--Dec 31, 2023
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%3,968-190-4.57%Dec 31, 2023
JANUS INVESTMENT FUND0.00%265,409--Dec 31, 2023
KP Funds0.00%36,910-1,068-2.81%Sep 30, 2020
THRIVENT SERIES FUND INC0.00%80,412-2,141-2.59%Dec 29, 2023
Cambria ETF Trust0.00%6,036--Jan 31, 2024
VANGUARD WHITEHALL FUNDS0.00%60,919--Jan 31, 2024
Invesco Exchange-Traded Fund Trust II0.00%200,039-96,481-32.54%Feb 29, 2024
TIAA-CREF LIFE FUNDS0.00%1,611--Dec 31, 2023
FundVantage Trust0.00%2,649--Jan 31, 2024
MAINSTAY VP FUNDS TRUST0.00%70,000--Dec 31, 2023

Corcept Therapeutics's largest mutual fund holder by % of total assets is "TANAKA FUNDS INC", owning 41.26K shares, compromising 1.84% of its total assets.

Corcept Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 243015.99%
31 Dec, 2328413.15%
30 Sep, 2325110.09%
30 Jun, 23228-6.56%
31 Mar, 23244-1.61%
31 Dec, 222483.77%
30 Sep, 222396.70%
30 Jun, 22224-0.44%
31 Mar, 222253.21%
31 Dec, 212184.31%
30 Sep, 212091.95%
30 Jun, 21205-4.65%
31 Mar, 21215-7.33%
31 Dec, 20232-0.43%
30 Sep, 20233-0.85%
30 Jun, 2023512.98%
31 Mar, 20208-3.70%
31 Dec, 192169.09%
30 Sep, 191984.76%
30 Jun, 19189-13.30%
31 Mar, 19218-6.84%
31 Dec, 182347.83%
30 Sep, 18217-5.24%
30 Jun, 182294.57%
31 Mar, 1821912.31%
31 Dec, 17195-4.41%
30 Sep, 1720422.89%
30 Jun, 1716619.42%
31 Mar, 171390.72%
31 Dec, 1613822.12%
30 Sep, 161130.89%
30 Jun, 1611216.67%
31 Mar, 1696-
31 Dec, 1596-
30 Sep, 159620.00%
30 Jun, 158026.98%
31 Mar, 156323.53%
31 Dec, 1451-3.77%
30 Sep, 1453-10.17%
30 Jun, 1459-
31 Mar, 145928.26%
31 Dec, 1346-16.36%
30 Sep, 13551.85%
30 Jun, 1354184.21%
31 Mar, 1319-9.52%
31 Dec, 1221-12.50%
30 Sep, 1224-14.29%
30 Jun, 122812.00%
31 Mar, 122519.05%
31 Dec, 112123.53%
30 Sep, 1117-29.17%
30 Jun, 112433.33%
31 Mar, 111812.50%
31 Dec, 101633.33%
30 Sep, 1012-7.69%
30 Jun, 1013160.00%
31 Mar, 105150.00%
31 Dec, 092-
30 Sep, 092-33.33%
30 Jun, 09350.00%
31 Mar, 092-50.00%
31 Dec, 08433.33%
30 Sep, 083-
30 Jun, 083-25.00%
31 Mar, 084-42.86%
31 Dec, 07716.67%
30 Sep, 07650.00%
30 Jun, 074-
31 Mar, 074-33.33%
31 Dec, 06620.00%
30 Sep, 065-28.57%
30 Jun, 06716.67%
31 Mar, 06620.00%
31 Dec, 05525.00%
30 Sep, 054-33.33%
30 Jun, 056-14.29%
31 Mar, 05740.00%
31 Dec, 04525.00%
30 Sep, 04433.33%
30 Jun, 043-

As of 31 Mar 24, 301 institutions are holding Corcept Therapeutics's shares, representing an increase of 5.99% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2492,278,0208.93%
31 Dec, 2384,711,5413.19%
30 Sep, 2382,090,5141.63%
30 Jun, 2380,775,851-7.59%
31 Mar, 2387,414,4214.86%
31 Dec, 2283,366,821-4.12%
30 Sep, 2286,948,6092.22%
30 Jun, 2285,058,6174.59%
31 Mar, 2281,325,2221.01%
31 Dec, 2180,510,320-0.38%
30 Sep, 2180,816,3110.45%
30 Jun, 2180,455,224-1.37%
31 Mar, 2181,574,465-3.11%
31 Dec, 2084,190,471-5.44%
30 Sep, 2089,037,853-0.61%
30 Jun, 2089,585,7591.48%
31 Mar, 2088,278,836-0.87%
31 Dec, 1989,052,6825.80%
30 Sep, 1984,173,018-2.35%
30 Jun, 1986,197,673-1.41%
31 Mar, 1987,426,110-3.85%
31 Dec, 1890,922,3011.47%
30 Sep, 1889,602,7172.33%
30 Jun, 1887,563,059-1.63%
31 Mar, 1889,014,3160.22%
31 Dec, 1788,816,69120.03%
30 Sep, 1773,997,2776.14%
30 Jun, 1769,715,38215.11%
31 Mar, 1760,564,51814.00%
31 Dec, 1653,126,7299.90%
30 Sep, 1648,341,5585.85%
30 Jun, 1645,669,24734.78%
31 Mar, 1633,883,712-0.79%
31 Dec, 1534,152,942-11.68%
30 Sep, 1538,668,29119.46%
30 Jun, 1532,368,4076.28%
31 Mar, 1530,455,3565.88%
31 Dec, 1428,764,205-1.83%
30 Sep, 1429,300,504-1.20%
30 Jun, 1429,656,990-2.51%
31 Mar, 1430,422,0257.82%
31 Dec, 1328,216,132-7.16%
30 Sep, 1330,390,596-1.75%
30 Jun, 1330,931,54064.68%
31 Mar, 1318,782,9341.54%
31 Dec, 1218,498,66128.54%
30 Sep, 1214,390,85964.31%
30 Jun, 128,758,3837.61%
31 Mar, 128,138,946-35.91%
31 Dec, 1112,698,34516.60%
30 Sep, 1110,890,354-8.16%
30 Jun, 1111,857,771274.72%
31 Mar, 113,164,42583.01%
31 Dec, 101,729,059-10.27%
30 Sep, 101,926,940-6.99%
30 Jun, 102,071,85983.63%
31 Mar, 101,128,282210.47%
31 Dec, 09363,414-40.92%
30 Sep, 09615,122-20.26%
30 Jun, 09771,41027.61%
31 Mar, 09604,510-33.91%
31 Dec, 08914,60820.41%
30 Sep, 08759,557-11.87%
30 Jun, 08861,863-48.44%
31 Mar, 081,671,500-10.92%
31 Dec, 071,876,304-23.00%
30 Sep, 072,436,616-3.18%
30 Jun, 072,516,671-5.49%
31 Mar, 072,662,787-0.91%
31 Dec, 062,687,1991.90%
30 Sep, 062,637,0840.91%
30 Jun, 062,613,353-0.19%
31 Mar, 062,618,3135.94%
31 Dec, 052,471,4011.94%
30 Sep, 052,424,403-3.90%
30 Jun, 052,522,8048.37%
31 Mar, 052,328,022-2.45%
31 Dec, 042,386,42010.42%
30 Sep, 042,161,1230.91%
30 Jun, 042,141,542-

Corcept Therapeutics (CORT) has 92.28M shares outstanding as of 31 Mar 24, up 8.93% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2490.07%1.35%
31 Dec, 2381.80%1.26%
30 Sep, 2380.51%1.44%
30 Jun, 2374.87%1.14%
31 Mar, 2381.03%1.35%
31 Dec, 2277.41%1.18%
30 Sep, 2281.17%1.27%
30 Jun, 2280.03%1.36%
31 Mar, 2276.71%1.53%
31 Dec, 2170.78%1.45%
30 Sep, 2169.80%1.46%
30 Jun, 2169.18%1.42%
31 Mar, 2169.83%1.33%
31 Dec, 2072.38%1.22%
30 Sep, 2076.93%1.27%
30 Jun, 2077.90%1.31%
31 Mar, 2077.05%1.27%
31 Dec, 1977.88%1.43%
30 Sep, 1973.92%1.30%
30 Jun, 1975.39%1.30%
31 Mar, 1976.13%1.22%
31 Dec, 1878.93%1.32%
30 Sep, 1877.38%1.35%
30 Jun, 1875.82%1.26%
31 Mar, 1877.48%1.27%
31 Dec, 1778.23%1.84%
30 Sep, 1765.14%1.72%
30 Jun, 1761.56%2.14%
31 Mar, 1753.66%2.42%
31 Dec, 1647.07%2.47%
30 Sep, 1643.69%2.54%
30 Jun, 1641.50%4.35%
31 Mar, 1630.90%3.03%
31 Dec, 1531.95%2.51%
30 Sep, 1535.65%3.96%
30 Jun, 1530.01%3.36%
31 Mar, 1529.89%3.68%
31 Dec, 1428.49%3.39%
30 Sep, 1428.97%3.36%
30 Jun, 1429.37%3.21%
31 Mar, 1430.26%3.84%
31 Dec, 1328.07%3.03%
30 Sep, 1330.45%3.17%
30 Jun, 1330.99%8.75%
31 Mar, 1318.82%4.76%
31 Dec, 1219.89%9.43%
30 Sep, 1214.52%14.87%
30 Jun, 129.88%10.63%
31 Mar, 129.64%4.26%
31 Dec, 1115.04%8.99%
30 Sep, 1112.94%6.49%
30 Jun, 1114.11%91.94%
31 Mar, 113.92%85.48%
31 Dec, 102.14%29.93%
30 Sep, 102.67%27.26%
30 Jun, 103.13%96.60%
31 Mar, 101.80%535.29%
31 Dec, 090.58%37.97%
30 Sep, 091.24%51.44%
30 Jun, 091.55%105.05%
31 Mar, 091.21%35.96%
31 Dec, 081.84%75.72%
30 Sep, 081.56%49.28%
30 Jun, 081.78%10.30%
31 Mar, 084.15%19.10%
31 Dec, 074.66%10.53%
30 Sep, 076.66%12.68%
30 Jun, 077.24%6.87%
31 Mar, 0710.27%7.42%
31 Dec, 0611.76%8.73%
30 Sep, 0611.61%8.75%
30 Jun, 0611.51%8.62%
31 Mar, 0611.56%9.67%
31 Dec, 0510.93%9.52%
30 Sep, 0510.72%8.60%
30 Jun, 0511.17%10.50%
31 Mar, 0510.31%6.16%
31 Dec, 0412.94%14.07%
30 Sep, 049.59%8.18%
30 Jun, 0410.83%-

As of 31 Mar 24, Corcept Therapeutics is held by 90.07% institutional shareholders, representing a 1.35% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 2416013.48%
31 Dec, 2314117.50%
30 Sep, 2312037.93%
30 Jun, 2387-29.84%
31 Mar, 23124-12.68%
31 Dec, 2214215.45%
30 Sep, 2212321.78%
30 Jun, 22101-5.61%
31 Mar, 2210710.31%
31 Dec, 219716.87%
30 Sep, 2183-1.19%
30 Jun, 2184-3.45%
31 Mar, 2187-7.45%
31 Dec, 2094-12.15%
30 Sep, 20107-10.83%
30 Jun, 2012010.09%
31 Mar, 201094.81%
31 Dec, 1910411.83%
30 Sep, 199316.25%
30 Jun, 1980-13.98%
31 Mar, 1993-21.85%
31 Dec, 181194.39%
30 Sep, 181143.64%
30 Jun, 18110-11.29%
31 Mar, 181247.83%
31 Dec, 171154.55%
30 Sep, 171106.80%
30 Jun, 1710356.06%
31 Mar, 1766-26.67%
31 Dec, 169036.36%
30 Sep, 1666-4.35%
30 Jun, 166950.00%
31 Mar, 1646-2.13%
31 Dec, 1547-12.96%
30 Sep, 1554-6.90%
30 Jun, 155865.71%
31 Mar, 153575.00%
31 Dec, 142033.33%
30 Sep, 1415-51.61%
30 Jun, 1431-18.42%
31 Mar, 1438100.00%
31 Dec, 1319-17.39%
30 Sep, 1323-41.03%
30 Jun, 1339290.00%
31 Mar, 1310-16.67%
31 Dec, 1212-7.69%
30 Sep, 1213-
30 Jun, 1213-13.33%
31 Mar, 121515.38%
31 Dec, 1113116.67%
30 Sep, 116-66.67%
30 Jun, 111828.57%
31 Mar, 111455.56%
31 Dec, 10980.00%
30 Sep, 105-50.00%
30 Jun, 1010150.00%
31 Mar, 104300.00%
31 Dec, 091-
30 Sep, 091-50.00%
30 Jun, 092100.00%
31 Mar, 091-
31 Dec, 081-
30 Sep, 081-
30 Jun, 08--100.00%
31 Mar, 081-
31 Dec, 071-66.67%
30 Sep, 073200.00%
30 Jun, 071-
31 Mar, 071-50.00%
31 Dec, 062100.00%
30 Sep, 061-
30 Jun, 061-66.67%
31 Mar, 063-
31 Dec, 05350.00%
30 Sep, 052-50.00%
30 Jun, 054-
31 Mar, 05433.33%
31 Dec, 043-
30 Sep, 043-
30 Jun, 043-

160 institutional shareholders have increased their position in CORT stock as of 31 Mar 24 compared to 141 in the previous quarter (a 13.48% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 2489-5.32%
31 Dec, 23942.17%
30 Sep, 2392-4.17%
30 Jun, 239624.68%
31 Mar, 237713.24%
31 Dec, 2268-9.33%
30 Sep, 2275-12.79%
30 Jun, 22864.88%
31 Mar, 2282-3.53%
31 Dec, 21857.59%
30 Sep, 21796.76%
30 Jun, 2174-14.94%
31 Mar, 2187-9.38%
31 Dec, 209617.07%
30 Sep, 208222.39%
30 Jun, 206715.52%
31 Mar, 2058-12.12%
31 Dec, 19664.76%
30 Sep, 1963-3.08%
30 Jun, 1965-13.33%
31 Mar, 197511.94%
31 Dec, 18674.69%
30 Sep, 1864-13.51%
30 Jun, 187412.12%
31 Mar, 186637.50%
31 Dec, 1748-5.88%
30 Sep, 175127.50%
30 Jun, 1740-23.08%
31 Mar, 175267.74%
31 Dec, 163155.00%
30 Sep, 1620-16.67%
30 Jun, 16244.35%
31 Mar, 1623-4.17%
31 Dec, 1524-11.11%
30 Sep, 152768.75%
30 Jun, 151623.08%
31 Mar, 1513-13.33%
31 Dec, 1415-21.05%
30 Sep, 1419-
30 Jun, 1419216.67%
31 Mar, 146-53.85%
31 Dec, 1313-13.33%
30 Sep, 131587.50%
30 Jun, 138100.00%
31 Mar, 134-42.86%
31 Dec, 127-
30 Sep, 127-
30 Jun, 12740.00%
31 Mar, 125-16.67%
31 Dec, 116-25.00%
30 Sep, 11860.00%
30 Jun, 115400.00%
31 Mar, 111-66.67%
31 Dec, 10350.00%
30 Sep, 102-33.33%
30 Jun, 103200.00%
31 Mar, 101-
31 Dec, 091-
30 Sep, 09--
30 Jun, 09--
31 Mar, 09--
31 Dec, 08--
30 Sep, 08--100.00%
30 Jun, 082100.00%
31 Mar, 081-66.67%
31 Dec, 073200.00%
30 Sep, 071-
30 Jun, 07--
31 Mar, 07--
31 Dec, 06--100.00%
30 Sep, 061-66.67%
30 Jun, 063-
31 Mar, 06--
31 Dec, 05--100.00%
30 Sep, 051-
30 Jun, 05--
31 Mar, 05--
31 Dec, 04--
30 Sep, 04--
30 Jun, 04--

89 institutional shareholders have reduced their position in CORT stock as of 31 Mar 24 compared to 94 in the previous quarter (a -5.32% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 243015.99%92,278,0208.93%90.07%1.35%16013.48%89-5.32%
31 Dec, 2328413.15%84,711,5413.19%81.80%1.26%14117.50%942.17%
30 Sep, 2325110.09%82,090,5141.63%80.51%1.44%12037.93%92-4.17%
30 Jun, 23228-6.56%80,775,851-7.59%74.87%1.14%87-29.84%9624.68%
31 Mar, 23244-1.61%87,414,4214.86%81.03%1.35%124-12.68%7713.24%
31 Dec, 222483.77%83,366,821-4.12%77.41%1.18%14215.45%68-9.33%
30 Sep, 222396.70%86,948,6092.22%81.17%1.27%12321.78%75-12.79%
30 Jun, 22224-0.44%85,058,6174.59%80.03%1.36%101-5.61%864.88%
31 Mar, 222253.21%81,325,2221.01%76.71%1.53%10710.31%82-3.53%
31 Dec, 212184.31%80,510,320-0.38%70.78%1.45%9716.87%857.59%
30 Sep, 212091.95%80,816,3110.45%69.80%1.46%83-1.19%796.76%
30 Jun, 21205-4.65%80,455,224-1.37%69.18%1.42%84-3.45%74-14.94%
31 Mar, 21215-7.33%81,574,465-3.11%69.83%1.33%87-7.45%87-9.38%
31 Dec, 20232-0.43%84,190,471-5.44%72.38%1.22%94-12.15%9617.07%
30 Sep, 20233-0.85%89,037,853-0.61%76.93%1.27%107-10.83%8222.39%
30 Jun, 2023512.98%89,585,7591.48%77.90%1.31%12010.09%6715.52%
31 Mar, 20208-3.70%88,278,836-0.87%77.05%1.27%1094.81%58-12.12%
31 Dec, 192169.09%89,052,6825.80%77.88%1.43%10411.83%664.76%
30 Sep, 191984.76%84,173,018-2.35%73.92%1.30%9316.25%63-3.08%
30 Jun, 19189-13.30%86,197,673-1.41%75.39%1.30%80-13.98%65-13.33%
31 Mar, 19218-6.84%87,426,110-3.85%76.13%1.22%93-21.85%7511.94%
31 Dec, 182347.83%90,922,3011.47%78.93%1.32%1194.39%674.69%
30 Sep, 18217-5.24%89,602,7172.33%77.38%1.35%1143.64%64-13.51%
30 Jun, 182294.57%87,563,059-1.63%75.82%1.26%110-11.29%7412.12%
31 Mar, 1821912.31%89,014,3160.22%77.48%1.27%1247.83%6637.50%
31 Dec, 17195-4.41%88,816,69120.03%78.23%1.84%1154.55%48-5.88%
30 Sep, 1720422.89%73,997,2776.14%65.14%1.72%1106.80%5127.50%
30 Jun, 1716619.42%69,715,38215.11%61.56%2.14%10356.06%40-23.08%
31 Mar, 171390.72%60,564,51814.00%53.66%2.42%66-26.67%5267.74%
31 Dec, 1613822.12%53,126,7299.90%47.07%2.47%9036.36%3155.00%
30 Sep, 161130.89%48,341,5585.85%43.69%2.54%66-4.35%20-16.67%
30 Jun, 1611216.67%45,669,24734.78%41.50%4.35%6950.00%244.35%
31 Mar, 1696-33,883,712-0.79%30.90%3.03%46-2.13%23-4.17%
31 Dec, 1596-34,152,942-11.68%31.95%2.51%47-12.96%24-11.11%
30 Sep, 159620.00%38,668,29119.46%35.65%3.96%54-6.90%2768.75%
30 Jun, 158026.98%32,368,4076.28%30.01%3.36%5865.71%1623.08%
31 Mar, 156323.53%30,455,3565.88%29.89%3.68%3575.00%13-13.33%
31 Dec, 1451-3.77%28,764,205-1.83%28.49%3.39%2033.33%15-21.05%
30 Sep, 1453-10.17%29,300,504-1.20%28.97%3.36%15-51.61%19-
30 Jun, 1459-29,656,990-2.51%29.37%3.21%31-18.42%19216.67%
31 Mar, 145928.26%30,422,0257.82%30.26%3.84%38100.00%6-53.85%
31 Dec, 1346-16.36%28,216,132-7.16%28.07%3.03%19-17.39%13-13.33%
30 Sep, 13551.85%30,390,596-1.75%30.45%3.17%23-41.03%1587.50%
30 Jun, 1354184.21%30,931,54064.68%30.99%8.75%39290.00%8100.00%
31 Mar, 1319-9.52%18,782,9341.54%18.82%4.76%10-16.67%4-42.86%
31 Dec, 1221-12.50%18,498,66128.54%19.89%9.43%12-7.69%7-
30 Sep, 1224-14.29%14,390,85964.31%14.52%14.87%13-7-
30 Jun, 122812.00%8,758,3837.61%9.88%10.63%13-13.33%740.00%
31 Mar, 122519.05%8,138,946-35.91%9.64%4.26%1515.38%5-16.67%
31 Dec, 112123.53%12,698,34516.60%15.04%8.99%13116.67%6-25.00%
30 Sep, 1117-29.17%10,890,354-8.16%12.94%6.49%6-66.67%860.00%
30 Jun, 112433.33%11,857,771274.72%14.11%91.94%1828.57%5400.00%
31 Mar, 111812.50%3,164,42583.01%3.92%85.48%1455.56%1-66.67%
31 Dec, 101633.33%1,729,059-10.27%2.14%29.93%980.00%350.00%
30 Sep, 1012-7.69%1,926,940-6.99%2.67%27.26%5-50.00%2-33.33%
30 Jun, 1013160.00%2,071,85983.63%3.13%96.60%10150.00%3200.00%
31 Mar, 105150.00%1,128,282210.47%1.80%535.29%4300.00%1-
31 Dec, 092-363,414-40.92%0.58%37.97%1-1-
30 Sep, 092-33.33%615,122-20.26%1.24%51.44%1-50.00%--
30 Jun, 09350.00%771,41027.61%1.55%105.05%2100.00%--
31 Mar, 092-50.00%604,510-33.91%1.21%35.96%1---
31 Dec, 08433.33%914,60820.41%1.84%75.72%1---
30 Sep, 083-759,557-11.87%1.56%49.28%1---100.00%
30 Jun, 083-25.00%861,863-48.44%1.78%10.30%--100.00%2100.00%
31 Mar, 084-42.86%1,671,500-10.92%4.15%19.10%1-1-66.67%
31 Dec, 07716.67%1,876,304-23.00%4.66%10.53%1-66.67%3200.00%
30 Sep, 07650.00%2,436,616-3.18%6.66%12.68%3200.00%1-
30 Jun, 074-2,516,671-5.49%7.24%6.87%1---
31 Mar, 074-33.33%2,662,787-0.91%10.27%7.42%1-50.00%--
31 Dec, 06620.00%2,687,1991.90%11.76%8.73%2100.00%--100.00%
30 Sep, 065-28.57%2,637,0840.91%11.61%8.75%1-1-66.67%
30 Jun, 06716.67%2,613,353-0.19%11.51%8.62%1-66.67%3-
31 Mar, 06620.00%2,618,3135.94%11.56%9.67%3---
31 Dec, 05525.00%2,471,4011.94%10.93%9.52%350.00%--100.00%
30 Sep, 054-33.33%2,424,403-3.90%10.72%8.60%2-50.00%1-
30 Jun, 056-14.29%2,522,8048.37%11.17%10.50%4---
31 Mar, 05740.00%2,328,022-2.45%10.31%6.16%433.33%--
31 Dec, 04525.00%2,386,42010.42%12.94%14.07%3---
30 Sep, 04433.33%2,161,1230.91%9.59%8.18%3---
30 Jun, 043-2,141,542-10.83%-3---

Corcept Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 15, 2024Maduck Seanofficer See RemarksS-SaleSell50,000$28.00$1.40M85,222
May 13, 2024Lyon Joseph Douglasofficer See RemarksS-SaleSell7,227$26.00$187.90K7,314
May 06, 2024Lyon Joseph Douglasofficer See RemarksS-SaleSell10,830$26.00$281.58K7,314
May 03, 2024Swisher Daniel N JRdirector-S-SaleSell2,200$23.09$50.80K-
Apr 08, 2024Lyon Joseph Douglasofficer See RemarksS-SaleSell5,443$26.00$141.52K7,314

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 15, 2024Maduck Seanofficer See RemarksS-SaleSell50,000$28.00$1.40M85,222
May 15, 2024Maduck Seanofficer See RemarksM-ExemptSell50,000$3.88$194.00K41,986
May 13, 2024Lyon Joseph Douglasofficer See RemarksM-ExemptSell7,227$11.35$82.03K19,167
May 13, 2024Lyon Joseph Douglasofficer See RemarksS-SaleSell7,227$26.00$187.90K7,314
May 06, 2024Lyon Joseph Douglasofficer See RemarksM-ExemptSell10,830$11.35$122.92K26,394
May 06, 2024Lyon Joseph Douglasofficer See RemarksS-SaleSell10,830$26.00$281.58K7,314
May 03, 2024Swisher Daniel N JRdirector-M-ExemptSell2,200$5.86$12.89K4,550
May 03, 2024Swisher Daniel N JRdirector-S-SaleSell2,200$23.09$50.80K-
Apr 12, 2024MAHONEY DAVID Ldirector-J-OtherSell27,806--27,806
Apr 12, 2024MAHONEY DAVID Ldirector-F-InKindSell2,194$23.80$52.22K27,806
Apr 12, 2024MAHONEY DAVID Ldirector-M-ExemptSell30,000$1.74$52.20K-
Apr 08, 2024Lyon Joseph Douglasofficer See RemarksM-ExemptSell5,443$11.35$61.78K37,224
Apr 08, 2024Lyon Joseph Douglasofficer See RemarksS-SaleSell5,443$26.00$141.52K7,314

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 15, 2024Maduck Seanofficer See RemarksM-ExemptBuy50,000$3.88$194.00K135,222
May 15, 2024Maduck Seanofficer See RemarksS-SaleSell50,000$28.00$1.40M85,222
May 15, 2024Maduck Seanofficer See RemarksM-ExemptSell50,000$3.88$194.00K41,986
May 13, 2024Lyon Joseph Douglasofficer See RemarksM-ExemptSell7,227$11.35$82.03K19,167
May 13, 2024Lyon Joseph Douglasofficer See RemarksM-ExemptBuy7,227$11.35$82.03K14,541
May 13, 2024Lyon Joseph Douglasofficer See RemarksS-SaleSell7,227$26.00$187.90K7,314
May 06, 2024Lyon Joseph Douglasofficer See RemarksM-ExemptSell10,830$11.35$122.92K26,394
May 06, 2024Lyon Joseph Douglasofficer See RemarksM-ExemptBuy10,830$11.35$122.92K18,144
May 06, 2024Lyon Joseph Douglasofficer See RemarksS-SaleSell10,830$26.00$281.58K7,314
May 03, 2024Swisher Daniel N JRdirector-M-ExemptSell2,200$5.86$12.89K4,550
May 03, 2024Swisher Daniel N JRdirector-M-ExemptBuy2,200$5.86$12.89K2,200
May 03, 2024Swisher Daniel N JRdirector-S-SaleSell2,200$23.09$50.80K-
Apr 12, 2024MAHONEY DAVID Ldirector-J-OtherBuy27,806--1,212,614
Apr 12, 2024MAHONEY DAVID Ldirector-M-ExemptBuy30,000$1.74$52.20K30,000
Apr 12, 2024MAHONEY DAVID Ldirector-J-OtherSell27,806--27,806
Apr 12, 2024MAHONEY DAVID Ldirector-F-InKindSell2,194$23.80$52.22K27,806
Apr 12, 2024MAHONEY DAVID Ldirector-M-ExemptSell30,000$1.74$52.20K-
Apr 08, 2024Lyon Joseph Douglasofficer See RemarksM-ExemptSell5,443$11.35$61.78K37,224
Apr 08, 2024Lyon Joseph Douglasofficer See RemarksM-ExemptBuy5,443$11.35$61.78K12,757
Apr 08, 2024Lyon Joseph Douglasofficer See RemarksS-SaleSell5,443$26.00$141.52K7,314

The last insider sell of Corcept Therapeutics's stock was made by Maduck Sean on May 15 2024, selling 50,000 shares at $28.00 per share (valued at $1.40M).

Corcept Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 202491752.94%
Q1 20242625104.00%
Q4 2023304075.00%
Q3 2023242885.71%
Q2 20232115140.00%
Q1 202317--
Q4 202231030.00%
Q3 2022212680.77%
Q2 2022168200.00%
Q1 202284200.00%
Q4 20212540.00%
Q3 202191656.25%
Q2 20212219115.79%
Q1 2021161888.89%
Q4 2020168200.00%
Q3 202062128.57%
Q2 202095180.00%
Q1 202051500.00%
Q4 20193837.50%
Q3 20191--

9 total buy trades, and 17 total sell trades (buy/sell ratio of 0.53%) were made by Corcept Therapeutics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-7-
Q1 2024-8-
Q4 2023-17-
Q3 2023-12-
Q2 2023-3-
Q1 2023---
Q4 2022-7-
Q3 2022-7-
Q2 2022-3-
Q1 2022-2-
Q4 2021-2-
Q3 2021-7-
Q2 20212450.00%
Q1 2021-8-
Q4 2020112550.00%
Q3 202021200.00%
Q2 2020-2-
Q1 2020---
Q4 2019-1-
Q3 2019---

As of Q2 2024, Insider owners conducted 0 open market buy trades and 7 open market sell trades of Corcept Therapeutics's stocks.

Corcept Therapeutics Peer Ownership


TickerCompany
MLYSMineralys Therapeutics, Inc.
HALOHalozyme Therapeutics, Inc.
ANABAnaptysBio, Inc.
DICEDICE Therapeutics, Inc.
CERECerevel Therapeutics Holdings, Inc.
KROSKeros Therapeutics, Inc.
NUVBNuvation Bio Inc.
IDYAIDEAYA Biosciences, Inc.
NXTCNextCure, Inc.
DYNDyne Therapeutics, Inc.
EWTXEdgewise Therapeutics, Inc.
SNSESensei Biotherapeutics, Inc.
ERASErasca, Inc.
GLUEMonte Rosa Therapeutics, Inc.
GRPHLENZ Therapeutics, Inc.
MGTXMeiraGTx Holdings plc
INSMInsmed Incorporated
CYTKCytokinetics, Incorporated
KRTXKaruna Therapeutics, Inc.
FIXXQ32 Bio Inc.
MACKMerrimack Pharmaceuticals, Inc.
RAREUltragenyx Pharmaceutical Inc.
AGIOAgios Pharmaceuticals, Inc.

CORT Ownership FAQ


Corcept Therapeutics is owned by institutional shareholders (90.07%), insiders (11.39%), and public (-1.46%). The largest institutional shareholder of Corcept Therapeutics is BLACKROCK INC. (16.42% of total shares) and the top mutual fund owner is TANAKA FUNDS INC (1.84% of total shares).

Corcept Therapeutics's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, INGALLS & SNYDER LLC, RENAISSANCE TECHNOLOGIES LLC, and PARALLEL ADVISORS, LLC. The top five shareholders own together 44.54% of the company's share outstanding.

As of Mar 2024, there are 301 institutional shareholders of Corcept Therapeutics.

BLACKROCK INC owns 16.83M shares of Corcept Therapeutics, representing 16.42% of the company's total shares outstanding, valued at $423.85M (as of Mar 2024).

As of Mar 2024, VANGUARD GROUP INC holds 9.57M shares of Corcept Therapeutics (CORT), compromising 9.34% of the company, valued at $240.96M.

INGALLS & SNYDER LLC is the third largest holder of Corcept Therapeutics. The company owns 8.3M of the company's shares outstanding (worth $209.16M).